Jan 13, 2017, 12.30 PM | Source: Moneycontrol.com
The company has launches Morphine Sulfate ER tablets 15 mg, 30 mg, 60 mg, 100 mg and 200 mg having received an approval from United State Food and Drug Administration (USFDA).
In a BSE filing, Lupin said, "It has launched its
In a BSE filing, Lupin said "it has received final
Lupin Ltd has informed BSE that a meeting of the B
Net Sales are expected to increase by 1.8 percent